MyFinsight
Home
Blog
About
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-98,000
-198,000
-100,767
-92,701
Return on Equity
32.394
80.786
176.104
-1,116.486
Net Profit Margin
-42.991
-136.029
-62.021
-112.805
Debt to Asset Ratio
122.468
117.67
104.765
98.643
Cash Ratio
35.613
53.846
109.635
59.558
Quick Ratio
155.84
185.231
234.115
173.814
Current Ratio
172.65
202.154
247.656
189.166
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Show more